Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna® for Multiple Sclerosis
Multiple sclerosis: Risk factors for progressive multifocal leukoencephalopathy identified in natalizumab-treated patients.
Gateway to wellness: an occupational therapy collaboration with the national multiple sclerosis society.
Treatment of Multiple Sclerosis With Chinese Scalp Acupuncture.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Sacral nerve stimulation for neurogenic bladder.
Immune modulation by a tolerogenic MOG10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model.
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
Diverse functional roles of lipocalin-2 in the central nervous system.
Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors.
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.
Combined sequence-based and genetic mapping analysis of complex traits in outbred rats.
Acute and subacute inflammation of the optic nerve and its sheath: clinical features in Chinese patients.
The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
In Vitro and In Vivo Models of Multiple Sclerosis.
Flash Pulmonary Edema in Multiple Sclerosis.
Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis.
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.
Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy.
Cognitive rehabilitation in Multiple sclerosis.
Advances in Antioxidative Therapy of Multiple Sclerosis.
Evidence linking HHV-6 with multiple sclerosis: an update.
Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.
Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis.
Pages
« first
‹ previous
…
258
259
260
261
262
263
264
265
266
…
next ›
last »